Commonwealth Equity Services
APGE

Commonwealth Equity Services’s Apogee Therapeutics APGE Stock Holding History

Commonwealth Equity Services’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$754K Sell
5,683
-232
-4% -$20.9K ﹤0.01% 2950
2026
Q1 		$498K Sell
5,915
-1,236
-17% -$89.8K ﹤0.01% 3210
2025
Q4 		$540K Buy
7,151
+152
+2% +$9.57K ﹤0.01% 3118
2025
Q3 		$278K Buy
6,999
+99
+1% +$3.78K ﹤0.01% 3717
2025
Q2 		$300K Buy
6,900
+398
+6% +$15.1K ﹤0.01% 3580
2025
Q1 		$243K Buy
6,502
+1,596
+33% +$61.7K ﹤0.01% 3674
2024
Q4 		$222K Buy
+4,906
New +$250K ﹤0.01% 3670

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Commonwealth Equity Services's APGE Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Apogee Therapeutics (APGE) stake by 3.9% in Q2 2026, selling an estimated $20.9K and leaving 5,683 shares worth $754K. The position accounts for ﹤0.01% of the portfolio, ranked #2950.

Commonwealth Equity Services first reported a position in APGE in Q4 2024 and has held it in 7 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Commonwealth Equity Services held 5,683 shares of Apogee Therapeutics worth $754K as of Q2 2026.
  • Commonwealth Equity Services sold 232 Apogee Therapeutics shares in Q2 2026, an estimated $20.9K.
  • Apogee Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2950 holding.
  • Commonwealth Equity Services first reported a position in Apogee Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.